Summarized by Masters of Longevity from PR Newswire.
Two-year data suggest diranersen slowed cognitive decline in early Alzheimer's.

Key Takeaways
- Two-year CELIA data showed a greater slowing of cognitive decline.
- The lowest dose was reported to have the best balance of benefit.
- Diranersen reduced tau while leaving amyloid measures largely unchanged.



